Trials / Completed
CompletedNCT06790732
Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery
The Effect of Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to evaluate the analgesic efficacy of preoperative ultrasound-guided peri-capsular nerve group block (PENG) on postoperative analgesia after shoulder arthroscopic surgery.
Detailed description
Postoperative pain control after shoulder surgery is challenging, and poor pain management is invariably reflected in poor outcomes, with longer hospitalization and recovery time. The difficulty in reducing pain due to the complexity of shoulder innervation leads to conducting studies to explore selective axillary nerve blocks with a posterior approach or from the axillae. The peri-capsular nerve group (PENG) block is a regional anesthetic technique. It can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. It targets only the sensory branches and not the posterior mechanoreceptors; there is a potential motor-sparing effect which is desirable for better physical therapy, and earlier discharge.
Conditions
- Preoperative
- Ultrasound-Guided
- PeriCapsular Nerve Group Block
- Postoperative Analgesia
- Shoulder Arthroscopic Surgery
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saline | Patients received sham PENG block (just 1mL saline). |
| DRUG | Bupivacaine + Dexamethasone | Patients received real PENG block (15 mL of bupivacaine 0.25% +0.2mg/mL dexamethasone). |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
- First posted
- 2025-01-24
- Last updated
- 2025-01-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06790732. Inclusion in this directory is not an endorsement.